Contrast Media Injectors Market – Global Forecast to 2029
The global contrast media injectors market is expected to reach USD 2.3 billion by 2029 from USD 1.6 billion in 2024, at a CAGR of 8.0% from 2024 to 2029.
世界の造影剤インジェクター市場は、2024年から2029年までCAGR 8.0%で、2024年の16億ドルから2029年までに23億ドルに達すると予想されています。
Aging population, coupled with a rise in cancer and heart diseases, has increased the demand for these products. Cardiovascular diseases are more prevalent in old-age population. Contrast media helps to better visualize the blood vessels and improves diagnostic confidence. Moreover, increased benefits of contrast-mediated procedures have driven demand for contrast media injectors.
This report provides insights on the following pointers:
• Analysis of key drivers (increasing prevalence of cancer and cardiovascular diseases, growing adoption of contrast-mediated CT and MRI procedures, growing approvals of contrast media), restraints (high cost of contrast media injectors systems), opportunities (rising healthcare expenditure across emerging countries), and challenges (dearth of trained professionals) influencing the growth of the contrast media injectors market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the contrast media injectors market
• Market Development: Comprehensive information about lucrative markets–the report analyses the contrast media injectors market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the contrast media injectors market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Bayer AG (Germany), Guerbet (France), Bracco Imaging S.p.A. (Italy), Ulrich GmbH & Co. Kg (Germany), Medtron AG (Germany), and Nemoto Kyorindo (Japan).